Skip to main content

Paul Schroder, MD, PhD

House Staff
College/University: 
John Carroll University
Medical School: 
The University of Toledo College of Medicine

Clinical and Research Interests

  • Clinical interest: Abdominal organ transplantation
  • Research interest: Transplantation immunology

What were you looking for in a residency program?

A program that would provide me with a well-rounded surgical education, a place that provided opportunity for me to do additional research in the field of transplant immunology, and a place that had a strong abdominal organ transplant program that I could engage with and learn from prior to embarking on fellowship training.

What are the strengths of the Duke program?

The Surgery faculty are excellent and committed to resident learning. The opportunities for research in a multitude of fields related to surgery or surgical sciences is also a strength of the program.

What advice do you have for incoming interns?

The more promising your talents, the harder you will be pushed and the better surgeon you will become. The first year will go by faster than you think. Learn all that you can.

What do you like best about living in Durham and the Triangle?

The cost of living is very reasonable and there are an abundance of outdoor activities to do as well as a temperate climate all year round.

What do you like to do outside of Duke?

I enjoy paddleboarding, playing golf, and music.

Honors and Awards

  • June 2019 Oral Presentation at the American Transplant Congress 2019
    • "Dual targeting desensitization with Carfilzomib plus Lulizumab significantly prolongs kidney transplant survival in allosensitized nonhuman primates." Paul M. Schroder*, Robin Schmitz, Zachary Fitch, Brian Ezekian, Janghoon Yoon, John Yi, Ashley Choi, Andrew Barbas, Frank Leopardi, Bradley Collins, Jean Kwun, and Stuart J. Knechtle
  • June 2019 Poster Presentations at the American Transplant Congress 2019
    • "Novel in vitro germinal center culture system demonstrates more aggressive B cell to plasmablast differentiation in allosensitized nonhuman primates." Paul M. Schroder*, Janghoon Yoon, Robin Schmitz, Zachary Fitch, Jean Kwun, and Stuart J. Knechtle.
    • "Pre-transplant multidimensional flow cytometric analysis of kidney transplant recipients reveals novel immune signature of allograft rejection." Paul M. Schroder*, John S. Yi, Kent J. Weinhold, Cliburn Chan, Marybeth Joshi, Christy Walters, Jean Kwun, and Stuart J. Knechtle.
  • April 2019 *Poster of Distinction Presented at Duke Surgery Research Day 2019
    • "Dual targeting desensitization with Carfilzomib plus Lulizumab significantly prolongs kidney transplant survival in allosensitized nonhuman primates." Paul M. Schroder*, Robin Schmitz, Zachary Fitch, Brian Ezekian, Janghoon Yoon, John Yi, Ashley Choi, Andrew Barbas, Frank Leopardi, Bradley Collins, Jean Kwun, and Stuart J. Knechtle
  • December 2018 Poster Presentations at the Great Lakes Transplant Immunology Forum 2018
    • "Desensitization with Carfilzomib Plus CD28dAb Significantly Improves Kidney Transplant Survival in Allosensitized Nonhuman Primates." Paul M. Schroder*, Robin Schmitz, Zachary Fitch, Brian Ezekian, Janghoon Yoon, Andrew Barbas, Frank Leopardi, Bradley Collins, Jean Kwun, and Stuart J. Knechtle.
    •  "Generation of an Efficient and Reliable Method for Modeling the Germinal Center Reaction In Vitro." Paul M. Schroder*, Janghoon Yoon, Jean Kwun, and Stuart J. Knechtle.
  • June 2018 Poster Presentations at the American Transplant Congress 2018
    • "Humoral Immunity to CMV Remains Intact after Dual Targeting Desensitization in Allosensitized Nonhuman Primates." Paul Schroder*, Brian Ezekian, Frances Saccoccio, Janghoon Yoon, Maria Dennis, Kyle Freischlag, Jean Kwun, Sallie Permar, and Stuart Knechtle.
  • February 2018 Oral Presentation at the Academic Surgical Congress 2018
    • "Identifying Factors that Decrease Utilization of Adjuvant Chemotherapy in Stage III Colon Cancer." Paul M. Schroder*, Megan C. Turner, Brian Ezekian, Zhifei Sun, Mohamed A. Adam, Christopher R. Mantyh, and John Migaly.

Publications

Schmitz, Robin, Zachary W. Fitch, Paul M. Schroder, Ashley Y. Choi, Annette M. Jackson, Stuart J. Knechtle, and Jean Kwun. “B cells in transplant tolerance and rejection: friends or foes?” Transplant International : Official Journal of the European Society for Organ Transplantation 33, no. 1 (January 2020): 30–40. https://doi.org/10.1111/tri.13549.

Full Text

Scheuermann, Uwe, Tracy Truong, Elisabeth R. Seyferth, Kyle Freischlag, Qimeng Gao, John Yerxa, Brian Ezekian, et al. “Kidney Donor Profile Index Is a Reliable Alternative to Liver Donor Risk Index in Quantifying Graft Quality in Liver Transplantation.” Transplant Direct 5, no. 12 (December 2019): e511. https://doi.org/10.1097/TXD.0000000000000955.

Full Text

Ezekian, Brian, Paul M. Schroder, Michael S. Mulvihill, Andrew Barbas, Bradley Collins, Kyle Freischlag, Janghoon Yoon, et al. “Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.” J Am Soc Nephrol 30, no. 12 (December 2019): 2399–2411. https://doi.org/10.1681/ASN.2019030304.

Full Text

Huang, Bingsong, Jun Liu, Jun Li, Paul M. Schroder, Maogen Chen, Ronghai Deng, and Suxiong Deng. “Once-daily prolonged-release tacrolimus versus twice-daily tacrolimus in liver transplantation.” Journal of the American Pharmacists Association : Japha 59, no. 6 (November 2019): 816-823.e2. https://doi.org/10.1016/j.japh.2019.08.002.

Full Text

Freischlag, Kyle, Brian Ezekian, Paul M. Schroder, Michael S. Mulvihill, Morgan L. Cox, Matthew G. Hartwig, and Stuart Knechtle. “A Propensity-matched Survival Analysis: Do Simultaneous Liver-lung Transplant Recipients Need a Liver?” In Transplantation, 103:1675–82, 2019. https://doi.org/10.1097/TP.0000000000002529.

Full Text

Schroder, Paul M., Zachary W. Fitch, Robin Schmitz, Ashley Y. Choi, Jean Kwun, and Stuart J. Knechtle. “The past, present, and future of costimulation blockade in organ transplantation.” Curr Opin Organ Transplant 24, no. 4 (August 2019): 391–401. https://doi.org/10.1097/MOT.0000000000000656.

Full Text

Kwun, J., B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, and S. Knechtle. “Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients.” In American Journal of Transplantation, 19:326–326. WILEY, 2019.

Scholars@Duke

Schmitz, R., M. S. Mulvihill, P. M. Schroder, Z. Fitch, F. Leopardi, D. Magnani, J. Kwun, S. J. Knechtle, and A. D. Kirk. “Depletional Induction Therapy in Non-Human Primates - Preclinical Modeling of Polyclonal Depletion with Rhesus-Specific ATG.” In American Journal of Transplantation, 19:597–597. WILEY, 2019.

Scholars@Duke

Schroder, P. M., R. Schmitz, Z. Fitch, B. Ezekian, J. Yoon, A. Choi, A. Barbas, et al. “Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates.” In American Journal of Transplantation, 19:429–429. WILEY, 2019.

Scholars@Duke

Schroder, P., J. Yoon, R. Schmitz, Z. Fitch, J. Kwun, and S. J. Knechtle. “Novel In Vitro Germinal Center Culture System Demonstrates More Aggressive B Cell to Plasma Blast Differentiation in Allosensitized Nonhuman Primates.” In American Journal of Transplantation, 19:1090–1090. WILEY, 2019.

Scholars@Duke

Pages